William N. Hait, M.D., Ph.D.

Former Executive Vice President and Chief External Innovation and Medical Officer, Johnson & Johnson

Education:

B.A. University of Pennsylvania

M.D. Medical College of Pennsylvania

Ph.D. Medical College of Pennsylvania - Pharmacology

 

Bio:

William N. Hait, M.D., Ph.D., is the former Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer, and member of the Johnson & Johnson Executive Committee. 

Dr. Hait joined J&J in 2007 and served as Global Therapeutic Area Head for Oncology from 2009 to 2011, and then as Global Head, Janssen Research & Development, from 2011 through 2018. In 2024, Dr. Hait retired from his position as Executive Vice President, Chief External Innovation and Medical Officer. Before that, he was the founding Director of The (Rutgers) Cancer Institute of New Jersey. From 1993 to 2007 he was Professor of Medicine and Pharmacology and Associate Dean for Oncology Programs at the University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School. 

Dr. Hait joined the Yale University School of Medicine faculty in 1984 and became Associate Professor of Medicine and Pharmacology, Chief of the Division of Medical Oncology, Associate Director of the Yale University Comprehensive Cancer Center, Director of the Breast Cancer Unit and Co-Director of the Lung Cancer Unit.  He is Board Certified in Internal Medicine and Medical Oncology. 

He devoted time to numerous advisory and editorial boards, served in a range of scientific functions, societies and committees, was elected President of the American Association for Cancer Research (2007 – 2008) and has received numerous awards and honors.